Telus is a better buy than BCE, this portfolio manager says

Telecom provider Telus Corp (Telus Stock Quote, Chart TSX:T) has a number of pluses going for it, not the least of which is its strong C-suite and alluring dividend, says Stephen Takacsy, president and CEO of Lester Asset Management, who says the company compares well with competitor BCE.

“Telus we like even more [then BCE] because it’s a pure play and it has one of the best CEOs in Canada in Darren Entwistle,” says Takacsy to BNN Bloomberg. “We own Telus as well as [BCE] but we have a bigger position in Telus. They’ve gone the pure play route and haven’t diversified into media.”

After a disappointing first half of 2018, Telus shares hit an all-time high in mid-August of $49.15, only to pull back in the weeks since. The stock is now even for the year, but that’s after losing seven per cent of its value over the first four months, as investors began vacating the telcos in response to rising interest rates.

Telus’ last earnings report in early August surprised with its wireless subscriber adds, although profit was flat with $390 million of net income, a 0.3 per cent year-over-year increase. CEO Entwistle stressed his company’s wireless customer loyalty and lifetime revenue, saying, “The second quarter was characterized by the best combined retention levels on record in respect of postpaid wireless, high-speed Internet and TV. This contributed to the strong customer growth, alongside continued value-creating financial results, driven by our team’s relentless focus on providing the best customer experience, buttressed by the ongoing generational investments we are making in our leading broadband networks.”

Takacsy makes note of Telus Health, the company’s foray into benefits and claims management. “Telus does have some other interesting high-growth components like health care, which is still a tiny part of their business but they’re growing quite aggressively,” he says. “So you get a little health care thrown in with the wireless, internet and broadband growth.”

“They’re past their peak capital expenditure so you’re going to see their dividend continue to grow quite nicely for many, many years to come,” he said.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: t
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

17 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

18 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago